• Rivaroxaban may be used in the treatment of LV thrombi. • Thrombus resolution took 30 days. • A large-scale randomized trial is needed to evaluate the use of DOACs in LV thrombi. • It is necessary to define the optimal dosing and timing if combined with DAPT.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451852 | PMC |
http://dx.doi.org/10.1016/j.case.2020.04.006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!